Vessel Co-option Is Common in Human Lung Metastases and Mediates Resistance to Anti-angiogenic Therapy in Preclinical Lung Metastasis Models

Cited by (214)

Items 201–214 of 214

1. Additional file 2 of The incorporation of acetylated LAP-TGF-β1 proteins into exosomes promotes TNBC cell dissemination in lung micro-metastasis
   Yu, Pei, Han, Yubao, Meng, Lulu, Zengying Tang, Zhiwei Jin, Zhang, Zhenzhen, Zhou, Yunjiang, Luo, Jun, Luo, Jianguang, Han, Chao et al. · 2024 · Figshare
2. Advancing lung cancer therapy – leveraging cell biology to improve immunotherapy and anti-angiogenic strategies
   Jozafina Haj-Shomaly, Alejandro Castillo‐Kauil, Carla Bloom, Kairbaan Hodivala‐Dilke, Gabriela D’Amico · 2026 · Journal of Cell Science
3. Vascular growth patterns correlate with histological subtypes in human lung adenocarcinoma
   Inés Solano-SC, Marta Rodríguez González, María González-Núñez · 2026 · Experimental and Molecular Pathology
4. Impact du microenvironnement dans la composition, la plasticité et la formation des invadosomes
   Elodie Henriet · 2017 · theses.fr (ABES)
5. Mathematical modelling of neoadjuvant antiangiogenic therapy and prediction of post-surgical metastatic relapse in breast cancer patients
   Chiara Nicolò · 2019
6. Le rôle des plaquettes dans la formation du microenvironnement tumoral
   Ophélie Le Chapelain · 2023
7. Acidosis Drives Vasculogenic Mimicry in PDAC CSCs via Na+/H+ Exchanger Isoform 1 (NHE1) and Calcium Entry
   Maria Raffaella Greco, Francesca Fracasso, Stefania Cannone, Daria Di Molfetta, Marilena Ardone, Sharon Natasha Cox, Brunella Rita Ladogana, Daniela Isabel Abbrescia, Apollonia Tullo, Marianna Ranieri et al. · 2026 · Cells
8. Endoglin (CD105) overexpression is associated with an immunosuppressive tumor microenvironment in murine lung cancer models and human lung adenocarcinoma
   Claudia Ollauri-Ibáñez, Blanca Ayuso-Íñigo, Inés Solano-SC · 2026 · Scientific Reports
9. Angiocrine factors in tumor microenvironment: bidirectional crosstalk, mechanistic insights, and therapeutic strategies
   Gaili Ji, Yaping Wang, Xiaoxue Li, Zuchen Yang, Luyao Kang, Yuehua Chen, Caixia Ma · 2026 · Journal of Translational Medicine
10. Comparative assessment of intratumoral sunitinib distribution and therapeutic response in matched primary and metastatic tumor models
    Anna Tisza, Szilvia Török, Yutaka Sugihara, Zsolt Horváth, Áron Gellert, Edina Bugyik, Judit Berta, Ildikó Kovács, Nándor Bárány, György Marko‐Varga et al. · 2026 · European Journal of Pharmacology
11. A Biology-Driven Framework for Selecting, Engineering, and Validating Physiologically Relevant Multicellular Tumour Models
    Ying‐Ta Wu, Darshan Tagadur Govindaraju, Girija M. Lakshmikanthacharya, Tzu-Yu Hsu, Chen-Fang Lin, Shashwat Sharma, T.S. Anilkumar · 2026 · Pharmaceutics
12. Lung cancer organoid models for studying resistance to anti-angiogenic therapy: Mechanisms and applications
    Hangfeng Lin, Keke Wang, Hao Chen, Guifei Tan, Junyao Zhu, Hai Liu, Jianqiong Yang · 2026 · Critical Reviews in Oncology/Hematology
13. The vascular–immune interface in breast cancer: normalization strategies, combination therapy, and biomarkers
    Yujing Zhang, Yulan Cai, Kaiguo Long, Qi Wang, Chuyu Liu, Feng Zeng · 2026 · Frontiers in Oncology
14. Histopathological growth patterns represent a dynamic biological and clinically-relevant terminus of the metastatic cascade
    Matthew Dankner, Sébastien Tabariès, Charlotte Girondel, Yasmine Sillis, Peter B. Vermeulen, Peter M. Siegel · 2026 · Cancer and Metastasis Reviews